Here are three quick notes:
1. The panel will take place in New York City at the Waldorf Astoria Hotel on Mon., Feb. 8, 2016, at 9:30 am EST.
2. The panel is titled “Advances in Ophthalmology: Therapies for Saving Sight” and will be moderated by Tony Gibney, managing director at Leerink Partners.
3. Inotek Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of therapies for glaucoma and other eye diseases.
More articles on healthcare:
Americans don’t think ACA is top issue in 2016 election — 5 things to know
7 things for ASC leaders to know for Monday — Feb. 1, 2016
Bernie Sanders is in good health, physician reports: 5 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.